Drug Shortage Report for ZYPREXA INTRAMUSCULAR
Report ID | 162425 |
Drug Identification Number | 02247099 |
Brand name | ZYPREXA INTRAMUSCULAR |
Common or Proper name | Olanzapine tartrate for injection |
Company Name | ELI LILLY CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 10MG |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 5 mL vial |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-06-24 |
Actual start date | 2022-06-24 |
Estimated end date | 2022-07-07 |
Actual end date | 2022-07-07 |
Shortage status | Resolved |
Updated date | 2022-07-08 |
Company comments | For any questions or concerns, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | EXCHANGE TOWER, 130 KING STREET WEST TORONTO, ONTARIO CANADA M5X 1B1 |
Company contact information | Lilly Canada’s Customer Response Centre 1-888-545-5972. |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v10 | 2022-07-08 | English | Compare |
v9 | 2022-07-07 | French | Compare |
v8 | 2022-07-07 | English | Compare |
v7 | 2022-07-07 | English | Compare |
v6 | 2022-06-27 | French | Compare |
v5 | 2022-06-27 | English | Compare |
v4 | 2022-06-25 | English | Compare |
v3 | 2022-06-10 | French | Compare |
v2 | 2022-06-10 | French | Compare |
v1 | 2022-06-10 | English | Compare |
Showing 1 to 10 of 10